Coherus Oncology

CHRS · NASDAQ

$1.00+$0.0413 (+4.31%)TodayMarket closed ·
Prev close $0.9587

Who owns CHRS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 37.4% of CHRS’s shares.

  • Timothy G. Youngquist 2020 Irrevocable Trust8.5%
  • BlackRock Institutional Trust Company, N.A.6.1%
  • Bering Capital LLC4.9%
  • Satterfield (Thomas A Jr)4.5%
  • Next 6 largest institutions13.5%
  • All other shareholders62.6%
Top institutional holders of CHRS
HolderShares% of shares
Timothy G. Youngquist 2020 Irrevocable Trust13.05M8.46%
BlackRock Institutional Trust Company, N.A.9.37M6.07%
Bering Capital LLC7.59M4.92%
Satterfield (Thomas A Jr)6.93M4.49%
Vanguard Capital Management, LLC5.95M3.86%
Geode Capital Management, L.L.C.3.69M2.39%
Samsara BioCapital, LLC3.43M2.22%
Kohlberg Kravis Roberts & Co. L.P.3.04M1.97%
State Street Investment Management (US)2.38M1.54%
Two Sigma Investments, LP2.27M1.47%

Largest mutual fund holders

Top mutual fund holders of CHRS
HolderShares% of shares
Vanguard Total Stock Market Index Fund3.95M2.56%
iShares Russell 2000 ETF3.20M2.08%
C WorldWide Healthcare Select Fund1.93M1.25%
Vanguard Extended Market Index Fund1.79M1.16%
Fidelity Small Cap Index Fund1.42M0.92%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of CHRS in the last 6 months.

Latest CHRS insider transactions
InsiderTypeSharesValue
Satvat Ali J.Award60.00K—
Satvat Ali J.Award30.00K—
Karachun Rita AAward60.00K—
Karachun Rita AAward30.00K—
Newcomer Lee NisleyAward60.00K—
Newcomer Lee NisleyAward30.00K—
Ryan Michael LeeAward60.00K—
Ryan Michael LeeAward30.00K—
O'Donnell-Tormey JillAward60.00K—
O'Donnell-Tormey JillAward30.00K—

Short interest

Settled Sep 30, 2026

Shares short
23.34M
Days to cover
12.53
% of shares outstanding
15.13%
Average daily volume
1.86M
Change since last report
+2.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.